4-Hydroxycoumarin Derivative: N-(diphenylmethyl)-2-[(2-oxo-2H-chromen-4-yl)oxy]acetamide Interaction with Human Serum Albumin

Figure 3

(a) Time-resolved emission spectroscopy (TRES) studies of HSA (1 µM) with the drug complex (1 µM) of different wavelength decay parameters. (b) Global fitted τ₀ value for each wavelength of the respective HSA and HSA-coumarin derivative.

(a)

(b)